Crossmark

Individualizing rTMS in treatment-resistant depression from patient-specific perfusion abnormalities a proof-of-concept randomized trial in comparison to standard rTMS and tDCS

Crossref DOI link: https://doi.org/10.1007/s00406-025-02027-7

Published Online: 2025-06-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dormegny-Jeanjean, Ludovic C. https://orcid.org/0000-0001-5405-2664
de Crespin de Billy, Clément

Pierrat, Camille

Mainberger, Olivier

Schorr, Benoit

Obrecht, Alexandre

Arcay, Hippolyte

Moreau, Augustin

Humbert, Ilia

Scarlatti, Francesco

Bertschy, Gilles

de Sousa, Paulo Loureiro

Lamy, Julien

Weibel, Sebastien

Landré, Lionel

Foucher, Jack R.
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct02863380 at ClinicalTrials.gov

Documents that mention this clinical trial

Individualizing rTMS in treatment-resistant depression from patient-specific perfusion abnormalities a proof-of-concept randomized trial in comparison to standard rTMS and tDCS
https://doi.org/10.1007/s00406-025-02027-7
Funding

Funding for this research was provided by:

Bpifrance (F1111009 A)
License Information

Text and Data Mining valid from 2025-06-14

Version of Record valid from 2025-06-14
More Information

Article History

Received: 9 January 2025

Accepted: 12 May 2025

First Online: 14 June 2025

Declarations

:

: The authors report no conflicts of interest associated with this publication.

Document is current

Any future updates will be listed below